New Immunotherapy Treatment for Lung Cancer, Tecentriq
Lung cancer is the third most common cancer in the United States. Now a newly FDA approved drug for patients with non-small cell lung cancer is proven to greatly improve survival.
| Other Authors: | Infobase,, Ivanhoe Broadcast News (Firm) |
|---|---|
| Format: | Video |
| Language: | English |
| Published: |
[Place of publication not identified] :
Ivanhoe Broadcast News,
[2020]
Distributed by Infobase, |
| Physical Description: |
1 online resource (1 video file (1 min., 1 sec)) : sound. |
| Series: |
Medical Breakthroughs.
|
| Subjects: |
CMU Electronic Access
Electronic Resource Click Here| Location | Call Number: | Status |
|---|---|---|
| CMU Electronic Access | Available |